Tag: Eugene Woltering
Carcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel
What are the most state-of-the-art treatments for carcinoid and NET cancer patients today? Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized…
READ MORE
Novartis Oncology Announces Winner of 2010 Warner Advocacy Award
Maryann Wahmann of the Carcinoid Cancer Awareness Network (CCAN) has been chosen as winner of the 2010 Warner Advocacy Award, established last year by Novartis Oncology to commemorate the life and work of the late Monica Warner of the Carcinoid Cancer…
READ MORE
2012 National Carcinoid & NETs Conference: Save the Date
Dr. Eugene A. Woltering, the Carcinoid Cancer Awareness Network (CCAN), and the New Orleans Neuroendocrine Tumor Specialist team at Ochsner Medical Center – Kenner in Louisiana have announced the dates for the 2012 National Carcinoid/NETs Conference…
READ MORE
Only 3 Days Left to Register for Carcinoid NET Patient Conference in California
There are only a few spots left and registration closes on July 5 for the 2010 San Francisco Carcinoid and Neuroendocrine Tumor Patient Conference, sponsored by InterScience Institute (ISI) and the Carcinoid Cancer Awareness Network (CCAN). Join …
READ MOREIs It Irritable Bowel Syndrome or Carcinoid Cancer? Think Zebras, Not Horses
So often misdiagnosed as irritable bowel syndrome or Crohn’s disease, carcinoid cancer is a diagnosis where doctors are thinking zebras not horses. The saying goes back to medical school when students are taught to consider the uncommon. “Ninety-nine…
READ MORE
2010 California & Virginia Carcinoid and Neuroendocrine Tumor Patient Conferences: Registration Is Now Open
InterScience Institute (ISI) and the Carcinoid Cancer Awareness Network (CCAN) are presenting their first joint conferences for carcinoid and neuroendocrine cancer patients on Saturday, July 17, 2010 in San Francisco, California, and on Saturday,…
READ MORE
